Photo from Peter de Gooyer/LinkedIn
Sep 20, 2024, 13:05
Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer
Top Biomedical Science shared a post on X about a recent paper by Peter de Gooyer et al. published in Nature Medicine.
Authors: Peter de Gooyer, Yara Verschoor, Lauren van den Dungen, Jose van den Berg, Myriam Chalabi et al.
“Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial.”
Source: Top Biomedical Science/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 15, 2025, 18:31
Jan 15, 2025, 18:25
Jan 15, 2025, 18:19
Jan 15, 2025, 17:48
Jan 15, 2025, 17:33
Jan 15, 2025, 17:27
Jan 15, 2025, 17:26
Jan 15, 2025, 17:19